These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 7900719)
1. Case-control study of bladder cancer and arsenic in drinking water. Bates MN; Smith AH; Cantor KP Am J Epidemiol; 1995 Mar; 141(6):523-30. PubMed ID: 7900719 [TBL] [Abstract][Full Text] [Related]
2. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Smith AH; Goycolea M; Haque R; Biggs ML Am J Epidemiol; 1998 Apr; 147(7):660-9. PubMed ID: 9554605 [TBL] [Abstract][Full Text] [Related]
3. Case-control study of bladder cancer and exposure to arsenic in Argentina. Bates MN; Rey OA; Biggs ML; Hopenhayn C; Moore LE; Kalman D; Steinmaus C; Smith AH Am J Epidemiol; 2004 Feb; 159(4):381-9. PubMed ID: 14769642 [TBL] [Abstract][Full Text] [Related]
4. Potential effect modifiers of the arsenic-bladder cancer risk relationship. Koutros S; Baris D; Waddell R; Beane Freeman LE; Colt JS; Schwenn M; Johnson A; Ward MH; Hosain GM; Moore LE; Stolzenberg-Solomon R; Rothman N; Karagas MR; Silverman DT Int J Cancer; 2018 Dec; 143(11):2640-2646. PubMed ID: 29981168 [TBL] [Abstract][Full Text] [Related]
5. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA. Meliker JR; Slotnick MJ; AvRuskin GA; Schottenfeld D; Jacquez GM; Wilson ML; Goovaerts P; Franzblau A; Nriagu JO Cancer Causes Control; 2010 May; 21(5):745-57. PubMed ID: 20084543 [TBL] [Abstract][Full Text] [Related]
6. Case-control study of bladder cancer and drinking water arsenic in the western United States. Steinmaus C; Yuan Y; Bates MN; Smith AH Am J Epidemiol; 2003 Dec; 158(12):1193-201. PubMed ID: 14652304 [TBL] [Abstract][Full Text] [Related]
7. Drinking water arsenic in northern chile: high cancer risks 40 years after exposure cessation. Steinmaus CM; Ferreccio C; Romo JA; Yuan Y; Cortes S; Marshall G; Moore LE; Balmes JR; Liaw J; Golden T; Smith AH Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):623-30. PubMed ID: 23355602 [TBL] [Abstract][Full Text] [Related]
8. Lung cancer and arsenic concentrations in drinking water in Chile. Ferreccio C; González C; Milosavjlevic V; Marshall G; Sancha AM; Smith AH Epidemiology; 2000 Nov; 11(6):673-9. PubMed ID: 11055628 [TBL] [Abstract][Full Text] [Related]
9. Intra-individual variability in toenail arsenic concentrations in a Michigan population, USA. Slotnick MJ; Meliker JR; Nriagu JO J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):149-57. PubMed ID: 17426735 [TBL] [Abstract][Full Text] [Related]
10. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Warner ML; Moore LE; Smith MT; Kalman DA; Fanning E; Smith AH Cancer Epidemiol Biomarkers Prev; 1994; 3(7):583-90. PubMed ID: 7827589 [TBL] [Abstract][Full Text] [Related]
11. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537 [TBL] [Abstract][Full Text] [Related]
12. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses. Tsuji JS; Alexander DD; Perez V; Mink PJ Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659 [TBL] [Abstract][Full Text] [Related]
13. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Kurttio P; Pukkala E; Kahelin H; Auvinen A; Pekkanen J Environ Health Perspect; 1999 Sep; 107(9):705-10. PubMed ID: 10464069 [TBL] [Abstract][Full Text] [Related]
14. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Moore LE; Smith AH; Hopenhayn-Rich C; Biggs ML; Kalman DA; Smith MT Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):31-6. PubMed ID: 8993795 [TBL] [Abstract][Full Text] [Related]
15. Nitrate in public water supplies and risk of bladder cancer. Ward MH; Cantor KP; Riley D; Merkle S; Lynch CF Epidemiology; 2003 Mar; 14(2):183-90. PubMed ID: 12606884 [TBL] [Abstract][Full Text] [Related]
16. Rationale for selecting exfoliated bladder cell micronuclei as potential biomarkers for arsenic genotoxicity. Smith AH; Hopenhayn-Rich C; Warner M; Biggs ML; Moore L; Smith MT J Toxicol Environ Health; 1993; 40(2-3):223-34. PubMed ID: 8230298 [TBL] [Abstract][Full Text] [Related]
17. Case-control study of bladder cancer and water disinfection methods in Colorado. McGeehin MA; Reif JS; Becher JC; Mangione EJ Am J Epidemiol; 1993 Oct; 138(7):492-501. PubMed ID: 8213753 [TBL] [Abstract][Full Text] [Related]
18. Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei. Biggs ML; Kalman DA; Moore LE; Hopenhayn-Rich C; Smith MT; Smith AH Mutat Res; 1997 Jun; 386(3):185-95. PubMed ID: 9219557 [TBL] [Abstract][Full Text] [Related]
19. Arsenic-related chromosomal alterations in bladder cancer. Moore LE; Smith AH; Eng C; Kalman D; DeVries S; Bhargava V; Chew K; Moore D; Ferreccio C; Rey OA; Waldman FM J Natl Cancer Inst; 2002 Nov; 94(22):1688-96. PubMed ID: 12441324 [TBL] [Abstract][Full Text] [Related]
20. What do I tell my patients about drinking water and the risk of bladder cancer? Moyad MA Urol Nurs; 2003 Oct; 23(5):371-7. PubMed ID: 14621363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]